Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,047 | 163 | 74.9% |
| Travel and Lodging | $1,089 | 5 | 16.2% |
| Consulting Fee | $600.00 | 1 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,803 | 76 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,462 | 11 | $0 (2020) |
| Abbott Laboratories | $1,189 | 13 | $0 (2024) |
| Biosense Webster, Inc. | $600.00 | 1 | $0 (2022) |
| Amgen Inc. | $293.87 | 13 | $0 (2024) |
| PFIZER INC. | $206.58 | 7 | $0 (2024) |
| Medtronic, Inc. | $144.47 | 3 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $131.26 | 8 | $0 (2019) |
| Relypsa, Inc. | $122.45 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $119.75 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,390 | 28 | Abbott Laboratories ($637.15) |
| 2023 | $874.83 | 33 | Abbott Laboratories ($325.36) |
| 2022 | $1,032 | 23 | Biosense Webster, Inc. ($600.00) |
| 2021 | $180.56 | 8 | BOSTON SCIENTIFIC CORPORATION ($167.47) |
| 2020 | $1,576 | 17 | Medtronic Vascular, Inc. ($1,462) |
| 2019 | $507.00 | 25 | Boston Scientific Corporation ($363.75) |
| 2018 | $627.56 | 20 | Boston Scientific Corporation ($179.11) |
| 2017 | $548.38 | 15 | BOSTON SCIENTIFIC CORPORATION ($209.25) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | Abbott Laboratories | TACTICATH ABLATION CATHETER, SENSOR ENABLED (Device) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: Electrophysiology | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: EMBLEM_CRM | ||||||
| 09/06/2024 | Boston Scientific Corporation | RESONATE EL ICD VR (Device) | Food and Beverage | In-kind items and services | $35.57 | General |
| Category: RESONATE_CRM | ||||||
| 09/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: General - Therapies_CRM | ||||||
| 08/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $42.53 | General |
| Category: General - Tachy_CRM | ||||||
| 08/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $34.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/23/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Ablation | ||||||
| 07/19/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $105.41 | General |
| Category: Electrophysiology | ||||||
| 07/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: General - Therapies_CRM | ||||||
| 07/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $59.70 | General |
| Category: General - Therapies_CRM | ||||||
| 07/01/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/18/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: LUX-Dx_CRM | ||||||
| 06/15/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $122.97 | General |
| Category: Pacemakers | ||||||
| 06/03/2024 | Abbott Laboratories | TACTICATH ABLATION CATHETER, SENSOR ENABLED (Device) | Food and Beverage | In-kind items and services | $178.56 | General |
| Category: Electrophysiology | ||||||
| 06/03/2024 | Abbott Laboratories | TACTICATH ABLATION CATHETER, SENSOR ENABLED (Device) | Food and Beverage | In-kind items and services | $170.93 | General |
| Category: Electrophysiology | ||||||
| 05/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $86.34 | General |
| Category: General - Therapies_CRM | ||||||
| 05/15/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $130.39 | General |
| Category: General - Therapies_CRM | ||||||
| 04/25/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: LUX-Dx_CRM | ||||||
| 04/17/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Genetic Disease | ||||||
| 03/26/2024 | Medtronic, Inc. | NA (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Ablation | ||||||
| 03/11/2024 | Boston Scientific Corporation | FINELINE II Sterox (Device) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: FINELINE_CRM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 58 | 3,495 | 9,405 | $952,680 | $358,440 |
| 2022 | 52 | 2,997 | 7,215 | $819,537 | $330,807 |
| 2021 | 54 | 3,450 | 9,044 | $954,474 | $387,112 |
| 2020 | 53 | 3,340 | 8,326 | $953,368 | $365,480 |
All Medicare Procedures & Services
217 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 327 | 455 | $129,675 | $47,454 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 252 | 324 | $129,600 | $47,119 | 36.4% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2023 | 57 | 553 | $69,678 | $24,099 | 34.6% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 17 | 17 | $58,344 | $23,379 | 40.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 175 | 810 | $56,700 | $22,495 | 39.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 194 | 259 | $34,188 | $17,880 | 52.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 119 | 199 | $40,795 | $15,768 | 38.7% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 18 | 19 | $45,030 | $15,017 | 33.3% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 17 | 34 | $19,856 | $14,192 | 71.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 74 | 80 | $38,050 | $13,579 | 35.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 204 | 454 | $39,948 | $11,537 | 28.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 453 | 744 | $28,272 | $8,949 | 31.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 20 | 20 | $23,160 | $8,202 | 35.4% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 68 | 68 | $20,400 | $8,040 | 39.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 41 | 41 | $19,967 | $7,430 | 37.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 20 | 40 | $9,400 | $7,196 | 76.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 60 | $13,560 | $6,121 | 45.1% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Office | 2023 | 18 | 18 | $15,300 | $4,838 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 73 | $11,826 | $4,503 | 38.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 23 | 92 | $9,948 | $3,950 | 39.7% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 186 | 328 | $11,480 | $3,841 | 33.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 60 | 119 | $14,620 | $3,588 | 24.5% |
| 75572 | Ct scan of heart structure with contrast | Office | 2023 | 15 | 15 | $9,960 | $3,275 | 32.9% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 21 | 34 | $6,460 | $3,245 | 50.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 27 | 27 | $7,695 | $3,042 | 39.5% |
About Dr. Eli Gang, M.D
Dr. Eli Gang, M.D is a Cardiovascular Disease healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861464166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eli Gang, M.D has received a total of $6,736 in payments from pharmaceutical and medical device companies, with $1,390 received in 2024. These payments were reported across 169 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,047).
As a Medicare-enrolled provider, Gang has provided services to 13,282 Medicare beneficiaries, totaling 33,990 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 217 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Beverly Hills, CA
- Active Since 02/02/2006
- Last Updated 12/14/2009
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1861464166
Products in Payments
- Arctic Front (Device) $1,462
- TACTICATH ABLATION CATHETER, SENSOR ENABLED (Device) $523.53
- AVEIR (Device) $372.33
- Repatha (Biological) $242.02
- ELIQUIS (Drug) $221.01
- RHYTHMIA (Device) $201.02
- SQ-RX PULSE GENERATOR (Device) $150.00
- MICRA (Device) $122.97
- Veltassa (Drug) $122.45
- PRALUENT (Drug) $115.65
- Advisor Catheter (Device) $114.33
- LUX-Dx Insertable Cardiac Monitor (Device) $109.78
- INTELLANAV (Device) $107.10
- ENSITE (Device) $105.41
- General - Therapies (Device) $96.43
- EMBLEM (Device) $86.61
- AMVUTTRA (Drug) $78.80
- CRT-Ds (Device) $73.04
- LUX DX (Device) $68.16
- CLINICAL TRIAL PRODUCT (Device) $65.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Beverly Hills
Dr. Bruce Samuels, M.d, M.D
Cardiovascular Disease — Payments: $820,416
Dr. Charles Swerdlow, M.d, M.D
Cardiovascular Disease — Payments: $596,658
Dr. David Filsoof, Md, MD
Cardiovascular Disease — Payments: $91,752
Mohammad Qureshi, Md, MD
Cardiovascular Disease — Payments: $75,839
Anil Mohin, M.d, M.D
Cardiovascular Disease — Payments: $28,093
Dr. Raj Khandwalla, Md, MD
Cardiovascular Disease — Payments: $24,943